Repeated stimulation by LPS promotes the senescence of DPSCs via TLR4/MyD88-NF-κB-p53/p21 signaling

Cytotechnology
Guijuan FengXingmei Feng

Abstract

Dental pulp stem cells (DPSCs), one type of mesenchymal stem cells, are considered to be a type of tool cells for regenerative medicine and tissue engineering. Our previous studies found that the stimulation with lipopolysaccharide (LPS) might introduce senescence of DPSCs, and this senescence would have a positive correlation with the concentration of LPS. The β-galactosidase (SA-β-gal) staining was used to evaluate the senescence of DPSCs and immunofluorescence to show the morphology of DPSCs. Our findings suggested that the activity of SA-β-gal has increased after repeated stimulation with LPS and the morphology of DPSCs has changed with the stimulation with LPS. We also found that LPS bound to the Toll-like receptor 4 (TLR4)/myeloid differentiation factor (MyD) 88 signaling pathway. Protein and mRNA expression of TLR4, MyD88 were enhanced in DPSCs with LPS stimulation, resulting in the activation of nuclear factor-κB (NF-κB) signaling, which exhibited the expression of p65 improved in the nucleus while the decreasing of IκB-α. Simultaneously, the expression of p53 and p21, the downstream proteins of the NF-κB signaling, has increased. In summary, DPSCs tend to undergo senescence after repeated stimulation in an inflammatory...Continue Reading

References

Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·G P DimriO Pereira-Smith
Jun 29, 2000·European Journal of Oral Sciences·R B Rutherford, K Gu
Sep 6, 2002·Biochemical Pharmacology·Jean-François DierickOlivier Toussaint
Apr 30, 2003·Cell Death and Differentiation·M Oren
Jul 29, 2003·Aging Cell·Jo S PriceIan M Clark
Aug 13, 2003·The EMBO Journal·Christian M BeauséjourJudith Campisi
Jul 2, 2004·Nature Reviews. Immunology·Shizuo Akira, Kiyoshi Takeda
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stefan DunzendorferPeter S Tobias
Apr 22, 2006·Aging Cell·Bo Yun LeeEun Seong Hwang
Oct 13, 2006·Immunology·Andrea BroadUNKNOWN Applied Immunology and Transplantation Research Group
Feb 29, 2008·Cytokine·Yong-Chen LuPamela S Ohashi
Dec 4, 2008·Critical Care Medicine·Ismail Cinel, Steven M Opal
Jan 30, 2010·Journal of Dental Research·T M BoteroJ E Nör
Feb 18, 2010·Cell Cycle·Jim O'PreyKevin M Ryan
May 15, 2010·Regenerative Medicine·Dominick J AlongiGeorge T-J Huang
Oct 7, 2011·Journal of Cellular Biochemistry·Xuechao YangMingwen Fan
Jan 18, 2012·Neuroimmunomodulation·Hong-Mei YuXi-Yin Wang
May 15, 2012·American Journal of Respiratory and Critical Care Medicine·Rosa FanerAlvar Agustí
Aug 23, 2012·Molecular Carcinogenesis·Bilge Debelec-ButunerKemal Sami Korkmaz
Aug 27, 2013·Endocrine-related Cancer·W Nathaniel BrennenJohn T Isaacs
Nov 28, 2013·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·Z GuZ Wang
Sep 11, 2014·Neural Regeneration Research·Cristina MantovaniValerio Magnaghi
Sep 13, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Faisal ImamSheikh Fayaz Ahmad
Dec 24, 2015·Stem Cell Research & Therapy·Catherine M KolfRocky S Tuan
Jan 1, 2016·Journal of Molecular and Cellular Cardiology·JoAnn TrialKatarzyna A Cieslik
Mar 30, 2016·Current Opinion in Cell Biology·Joseph R TranYixian Zheng
Jun 16, 2016·Journal of Dental Research·B D SuiY Jin

❮ Previous
Next ❯

Citations

Jul 28, 2020·Cells·Daniel HumphreysTeresa Frisan
Nov 19, 2019·International Immunopharmacology·Jianwei SunJiajie Zhang
Sep 9, 2019·ACS Biomaterials Science & Engineering·Ningxin ZhuYuanyuan Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.